Sufficient evidence outlines the pathological changes following TBI and their similarity to dopaminergic abnormalities, α-synuclein aggregation, S100A9 accumulation, and pro-inflammatory cytokines and ROS release in PD patients. Here, S100A9 is linked to Parkinson disease.